Edwin Cuperus
Research Subjects
Edwin Cuperus has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Has
Department of Dermatology and Venereology, Faculty of Medicine and Medical Center University Hospital Freiburg Freiburg Germany
2 shared publications - Suzanne G. M. A. Pasmans
Department of Dermatology, Erasmus MC, Rotterdam, the Netherlands
2 shared publications A. Bygum
Department of Clinical Genetics Clinical Institute Denmark & Odense University Hospital University of Southern Denmark Odense Denmark
1 shared publicationA. Hernández‐Martín
Department of Dermatology Hospital Infantil Niño Jesús Madrid Spain
1 shared publicationA.E. Martinez
Pediatric Dermatology NHS Foundation Trust London UK
1 shared publication- Adam S. Arterbery
The Jackson Laboratory for Genomic Medicine , Farmington, CT
1 shared publication
Latest Publications
- 16 June 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (3) , 535-537
In-depth human phenotype ontology curation boosts prioritization performance for Netherton syndrome ( SPINK5 -syndromic epidermal differentiation disorder)
This study brings the Human Phenotype Ontology into dermatology, refining and expanding its use for Netherton syndrome (SPINK5-sEDD). The updated terms significantly boost diagnostic performance and enhance clinical phenotyping. It highlights the promise of ontology-based tools for rare skin diseases.
- 16 June 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (3) , 535-537
In-depth human phenotype ontology curation boosts prioritization performance for Netherton syndrome ( SPINK5 -syndromic epidermal differentiation disorder)
This study brings the Human Phenotype Ontology into dermatology, refining and expanding its use for Netherton syndrome (SPINK5-sEDD). The updated terms significantly boost diagnostic performance and enhance clinical phenotyping. It highlights the promise of ontology-based tools for rare skin diseases.
- Open Access
- 15 March 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (7) , 973-986
Proposal for a 6‐step approach for differential diagnosis of neonatal erythroderma
The broad differential diagnosis of neonatal erythroderma often poses a diagnostic challenge. Mortality of neonatal erythroderma is high due to complications of the erythroderma itself and the occasionally severe and life‐threatening underlying disease. Early correct recognition of the underlying cause leads to better treatment and prognosis. Currently, neonatal erythroderma is approached on a case‐by‐case basis. The purpose of this scoping review was to develop a diagnostic approach in neonatal erythroderma. After a systematic literature search in Embase (January 1990 – May 2020, 74 cases of neonatal erythroderma were identified, and 50+ diagnoses could be extracted. Main causes were the ichthyoses (40%) and primary immunodeficiencies (35%). Congenital erythroderma was present in 64% (47/74) of the cases, predominantly with congenital ichthyosis (11/11; 100%), Netherton syndrome (12/14, 86%) and Omenn syndrome (11/23, 48%). Time until diagnosis ranged from 102 days to 116 days for cases of non‐congenital erythroderma and congenital erythroderma respectively. Among the 74 identified cases a total of 17 patients (23%) died within a mean of 158 days and were related to Omenn syndrome (35%), graft‐versus‐host disease (67%) and Netherton syndrome (18%). Disease history and physical examination are summarized in this paper. Age of onset and a collodion membrane can help to narrow the differential diagnoses. Investigations of blood, histology, hair analysis, genetic analysis and clinical imaging are summarized and discussed. A standard blood investigation is proposed, and the need for skin biopsies with lympho‐epithelial Kazal‐type related Inhibitor staining is highlighted. Overall, this review shows that diagnostic procedures narrow the differential diagnosis in neonatal erythroderma. A 6‐step flowchart for the diagnostic approach for neonatal erythroderma during the first month of life is proposed. The approach was made with the support of expert leaders from international multidisciplinary collaborations in the European Reference Network Skin‐subthematic group Ichthyosis.
- 15 March 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (7) , 973-986
Open AccessProposal for a 6‐step approach for differential diagnosis of neonatal erythroderma
The broad differential diagnosis of neonatal erythroderma often poses a diagnostic challenge. Mortality of neonatal erythroderma is high due to complications of the erythroderma itself and the occasionally severe and life‐threatening underlying disease. Early correct recognition of the underlying cause leads to better treatment and prognosis. Currently, neonatal erythroderma is approached on a case‐by‐case basis. The purpose of this scoping review was to develop a diagnostic approach in neonatal erythroderma. After a systematic literature search in Embase (January 1990 – May 2020, 74 cases of neonatal erythroderma were identified, and 50+ diagnoses could be extracted. Main causes were the ichthyoses (40%) and primary immunodeficiencies (35%). Congenital erythroderma was present in 64% (47/74) of the cases, predominantly with congenital ichthyosis (11/11; 100%), Netherton syndrome (12/14, 86%) and Omenn syndrome (11/23, 48%). Time until diagnosis ranged from 102 days to 116 days for cases of non‐congenital erythroderma and congenital erythroderma respectively. Among the 74 identified cases a total of 17 patients (23%) died within a mean of 158 days and were related to Omenn syndrome (35%), graft‐versus‐host disease (67%) and Netherton syndrome (18%). Disease history and physical examination are summarized in this paper. Age of onset and a collodion membrane can help to narrow the differential diagnoses. Investigations of blood, histology, hair analysis, genetic analysis and clinical imaging are summarized and discussed. A standard blood investigation is proposed, and the need for skin biopsies with lympho‐epithelial Kazal‐type related Inhibitor staining is highlighted. Overall, this review shows that diagnostic procedures narrow the differential diagnosis in neonatal erythroderma. A 6‐step flowchart for the diagnostic approach for neonatal erythroderma during the first month of life is proposed. The approach was made with the support of expert leaders from international multidisciplinary collaborations in the European Reference Network Skin‐subthematic group Ichthyosis.